S, W., & X, L. (2020). CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press.
Style de citation Chicago (17e éd.)S, Wang, et Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)S, Wang, et Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.